Author:
Publisher:
ISBN:
Category : Drug packaging industry
Languages : en
Pages : 36
Book Description
Guideline for Submitting Documentation for Packaging for Human Drugs and Biologics
Author:
Publisher:
ISBN:
Category : Drug packaging industry
Languages : en
Pages : 36
Book Description
Publisher:
ISBN:
Category : Drug packaging industry
Languages : en
Pages : 36
Book Description
Guideline for Submitting Documentation for Packaging for Human Drugs and Biologics
Author: Center for Drugs and Biologics
Publisher:
ISBN:
Category :
Languages : en
Pages : 52
Book Description
Publisher:
ISBN:
Category :
Languages : en
Pages : 52
Book Description
Guideline for Submitting Documentation for the Stability of Human Drugs and Biologics
Author:
Publisher:
ISBN:
Category : Biological products
Languages : en
Pages : 76
Book Description
Publisher:
ISBN:
Category : Biological products
Languages : en
Pages : 76
Book Description
Guideline for Submitting Documentation for Packaging for Human Drugs and Biologics
Author:
Publisher:
ISBN:
Category : Drug packaging industry
Languages : en
Pages : 44
Book Description
Publisher:
ISBN:
Category : Drug packaging industry
Languages : en
Pages : 44
Book Description
Guideline for Submitting Documentation for the Manufacture of and Controls for Drug Products
Guideline for the Format and Content of the Chemistry, Manufacturing, and Controls Section of an Application
The Regulatory Compliance Almanac
Author: Les Schnoll
Publisher: Paton Professional
ISBN: 9781932828191
Category : Law
Languages : en
Pages : 564
Book Description
Publisher: Paton Professional
ISBN: 9781932828191
Category : Law
Languages : en
Pages : 564
Book Description
Federal Register
Author:
Publisher:
ISBN:
Category : Administrative law
Languages : en
Pages : 1068
Book Description
Publisher:
ISBN:
Category : Administrative law
Languages : en
Pages : 1068
Book Description
Peptide Therapeutics
Author: Ved Srivastava
Publisher: Royal Society of Chemistry
ISBN: 1788014332
Category : Science
Languages : en
Pages : 572
Book Description
Peptide therapy has become a key strategy in innovative drug development, however, one of the potential barriers for the development of novel peptide drugs in the clinic is their deficiencies in clearly defined chemistry, manufacturing and controls (CMC) strategy from clinical development to commercialization. CMC can often become a rate-limiting step due to lack of knowledge and lack of a formal policy or guidelines on CMC for peptide-based drugs. Regulators use a risk-based approach, reviewing applications on a case-by-case basis. Peptide Therapeutics: Strategy and Tactics for Chemistry, Manufacturing, and Controls covers efficient manufacturing of peptide drug substances, a review of the process for submitting applications to the regulatory authority for drug approval, a holistic approach for quality attributes and quality control from a regulatory perspective, emerging analytical tools for the characterisation of impurities, and the assessment of stability. This book is an essential reference work for students and researchers, in both academia and industry, with an interest in learning about CMC, and facilitating development and manufacture of peptide-based drugs.
Publisher: Royal Society of Chemistry
ISBN: 1788014332
Category : Science
Languages : en
Pages : 572
Book Description
Peptide therapy has become a key strategy in innovative drug development, however, one of the potential barriers for the development of novel peptide drugs in the clinic is their deficiencies in clearly defined chemistry, manufacturing and controls (CMC) strategy from clinical development to commercialization. CMC can often become a rate-limiting step due to lack of knowledge and lack of a formal policy or guidelines on CMC for peptide-based drugs. Regulators use a risk-based approach, reviewing applications on a case-by-case basis. Peptide Therapeutics: Strategy and Tactics for Chemistry, Manufacturing, and Controls covers efficient manufacturing of peptide drug substances, a review of the process for submitting applications to the regulatory authority for drug approval, a holistic approach for quality attributes and quality control from a regulatory perspective, emerging analytical tools for the characterisation of impurities, and the assessment of stability. This book is an essential reference work for students and researchers, in both academia and industry, with an interest in learning about CMC, and facilitating development and manufacture of peptide-based drugs.
Chemists’ Views of Imaging Centers
Author: Ali M. Emran
Publisher: Springer Science & Business Media
ISBN: 1475796706
Category : Medical
Languages : en
Pages : 528
Book Description
To continue the support for the growing trend of chemistry involvement in nuclear medicine, the Division of Nuclear Chemistry and Technology (DNCT) of the American Chemical Society (ACS) planned for a symposium to cover this aspect. This was expressed in arequest to me, as a member of the Program Committee, to organize a symposium on topics related to nuclear and radiochemistry applications to nuclear medicine. Realizing the growing interest in imaging, specially with positron emitting radioisotopes, I invited several colleagues to study with me the idea of imaging centers and the involvement of chemists in their structure and function. The formulated Organizing Committee supported this idea which evolved in proposing an extended international symposium to be held in conjunction with the 206th ACS National meeting in Chicago, Illinois, U. S. A. on August 22-27, 1993. The following are the members of the Organizing Committee: Jorge R. Barrio, Ph. D. Thomas E. Boothe, Ph. D. J. Robert Dahl, Ph. D. Robert F. Dannals, Ph. D. Bruce R. Erdal, Ph. D. Mark M. Goodman, Ph. D. George W. Kabalka, Ph. D. James F. Lamb, Ph. D. Ronald G. Manning, Ph. D. Henry C. Padgett, Ph. D. Roy S. Tilbury, Ph. D. Steven W. Yates, Ph. D. and Ali M. Emran, Ph. D.
Publisher: Springer Science & Business Media
ISBN: 1475796706
Category : Medical
Languages : en
Pages : 528
Book Description
To continue the support for the growing trend of chemistry involvement in nuclear medicine, the Division of Nuclear Chemistry and Technology (DNCT) of the American Chemical Society (ACS) planned for a symposium to cover this aspect. This was expressed in arequest to me, as a member of the Program Committee, to organize a symposium on topics related to nuclear and radiochemistry applications to nuclear medicine. Realizing the growing interest in imaging, specially with positron emitting radioisotopes, I invited several colleagues to study with me the idea of imaging centers and the involvement of chemists in their structure and function. The formulated Organizing Committee supported this idea which evolved in proposing an extended international symposium to be held in conjunction with the 206th ACS National meeting in Chicago, Illinois, U. S. A. on August 22-27, 1993. The following are the members of the Organizing Committee: Jorge R. Barrio, Ph. D. Thomas E. Boothe, Ph. D. J. Robert Dahl, Ph. D. Robert F. Dannals, Ph. D. Bruce R. Erdal, Ph. D. Mark M. Goodman, Ph. D. George W. Kabalka, Ph. D. James F. Lamb, Ph. D. Ronald G. Manning, Ph. D. Henry C. Padgett, Ph. D. Roy S. Tilbury, Ph. D. Steven W. Yates, Ph. D. and Ali M. Emran, Ph. D.